Short description
Electra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases.
Description
Electra Therapeutics is a clinical stage biotechnology company developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer. Electra currently has one program in clinical development and two additional preclinical programs. The company’s lead product candidate, ELA026, is a monoclonal antibody that targets SIRP on the cell surface of myeloid and T cells, and depletes pathological immune cells. ELA026 is in clinical development for secondary hemophagocytic lymphohistiocytosis (sHLH), a life-threatening hyperinflammatory condition for which there is no approved treatment.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
San Francisco, California, United States, North America
Founded on
October 12, 2018
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
Blurry Noaccess, Noaccess, Noaccess, No Way, Uh Ohhhh, Noway Youcantaccess, Blurry Noaccess
Sign in for full access
Founders
Adam Rosenthal